GEM
MOLECULAR TARGETGTP binding protein overexpressed in skeletal muscle
GEM (GTP binding protein overexpressed in skeletal muscle) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GEM
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 2 | Genistein | 0.69 | 1 |
| 3 | piceatannol | 0.69 | 1 |
About GEM as a Drug Target
GEM (GTP binding protein overexpressed in skeletal muscle) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented GEM interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GEM inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.